Approvals/CIMA-AEMPS/VENLAFAXINA RETARD NORMOGEN 37,5 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG

Approved

STANDARD

VENLAFAXINA RETARD NORMOGEN 37,5 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG

Laboratorios Normon S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8e86d88b626ece82
Drug Cima Aemps Name: VENLAFAXINA RETARD NORMOGEN 37,5 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG
Register Number: 89306
Holder Company Name: Laboratorios Normon S.A.
Marketing Company Name: Laboratorios Normon S.A.
Authorization Date: 2024-02-07
Dosage Form: CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose: 37,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratorios Normon S.A.

VENLAFAXINA HIDROCLORURO

42,450 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 7, 2024

Approval ID

8e86d88b626ece82

Type

Standard